Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) - Global Forecast to 2026

世界の細胞解離市場予測:製品別、種類別、組織別、エンドユーザー別

◆タイトル:Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) - Global Forecast to 2026
◆商品コード:BT6129
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年5月11日
◆ページ数:212
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は世界の細胞解離市場規模が2021年282百万ドルから2026年561百万ドルまで、年平均14.7%成長すると予測しています。本調査レポートでは、細胞解離の世界市場について調査・分析し、イントロダクション、調査手法、市場概要、エグゼクティブサマリー、プレミアムインサイト、製品別(細胞解離製品、非細胞解離製品、器具・付属品)分析、組織別(結合組織、上皮組織、その他)分析、種類別(組織解離、細胞剥離)分析、エンドユーザー別(製薬・バイオテクノロジー企業、研究・学術機関、その他)分析、地域別分析、競争状況、企業情報などを掲載しております。
・イントロダクション
・調査手法
・市場概要
・エグゼクティブサマリー
・プレミアムインサイト
・世界の細胞解離市場規模:製品別(細胞解離製品、非細胞解離製品、器具・付属品)
・世界の細胞解離市場規模:組織別(結合組織、上皮組織、その他)
・世界の細胞解離市場規模:種類別(組織解離、細胞剥離)
・世界の細胞解離市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、研究・学術機関、その他)
・世界の細胞解離市場規模:地域別
・競争状況
・企業情報

“The global cell dissociation market size is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7% during the forecast period.”
The growth in this market is attributed to the prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies. Moreover, the growth opportunities in emerging markets are expected to provide growth opportunities for players in the cell dissociation market during the forecast period.

“Enzymatic dissociation products segment to witness the highest growth during the forecast period.”
Based on the product, the cell dissociation market is segmented into Enzymatic dissociation products, Non-Enzymatic dissociation products and instruments. The Enzymatic dissociation products segment is projected to grow at the highest CAGR during the forecast period. The large share of this segment can be attributed increasing incidence of cell based research is the major factor supporting the growth of this segment.

“Connective tissue segment to register the highest growth in the cell dissociation market during the forecast period.”
Based on the tissue, the cell dissociation market is segmented into connective tissues, epethilial tissues and other tissues (skeletal, muscles tissues). The connective tissues segment is projected to witness the highest growth in the cell dissociation market during the forecast period. The large share of this segment can be attributed to cell based research and development in pharmaceutical and biotechnology companies.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the cell dissociation market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by The increasing fundind for cell based research .

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)
• By Designation: C-level (30%), Director-level (34%), and Others (36%)
• By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)

List of Companies Profiled in the Report
• Thermo Fisher Scientific (US)
• Becton, Dickinson and Company (US)
• Roche Diagnostics (Switzerland)
• Cytiva (a part of Danaher Corporation) (US)
• STEMCELL Technologies (Canada)
• Miltenyi Biotec (Germany)
• PromoCell GmbH (Germany)
• AcceGen(US), VitaCyte (US)
• Alstem (US)
• Biological Industries (Israel)
• Gemini Bio (US)
• Innovative Cell Technologies (US)
• Central Drug House (India)
• Worthington Biochemical Corporation (US)
• Capricorn Scientific (Germany)
• Abeomics (US)
• Genlantis (US)
• Neuromics (US)

Research Coverage
This report studies the cell dissociation market based on product, technology, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell dissociation market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on cell dissociation products offered by the top 27 players in the cell dissociation market. The report analyzes the cell dissociation market by product, tissue, type, end user, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the cell dissociation market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell dissociation market

【レポートの目次】

1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY 28
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED FOR THE STUDY 29
1.4 CURRENCY 30
1.5 LIMITATIONS 30
1.6 MARKET STAKEHOLDERS 30
1.7 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 33
2.1.1.1 Secondary sources 34
2.1.2 PRIMARY DATA 34
FIGURE 2 PRIMARY SOURCES 35
2.1.2.1 Key data from primary sources 36
2.1.2.2 Key industry insights 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 37
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 38
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
FIGURE 6 TOP-DOWN APPROACH 40
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 41
FIGURE 7 DATA TRIANGULATION METHODOLOGY 41
2.4 MARKET SHARE ANALYSIS 42
2.5 ASSUMPTIONS FOR THE STUDY 42
2.6 COVID-19 HEALTH ASSESSMENT 43
2.7 COVID-19 ECONOMIC ASSESSMENT 43
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 43
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 44
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 45

3 MARKET OVERVIEW 46
3.1 INTRODUCTION 46
3.2 MARKET DYNAMICS 46
FIGURE 10 CELL DISSOCIATION MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 46
3.2.1 DRIVERS 47
3.2.1.1 Increasing R&D activities in biopharmaceutical companies 47
TABLE 1 R&D EXPENDITURE OF MAJOR BIOPHARMACEUTICAL COMPANIES,
2019 VS. 2020 47
3.2.1.2 Favorable funding scenario for cancer research 47
FIGURE 11 NIH FUNDING, BY RESEARCH AREA, 2016–2021 (USD MILLION) 48
3.2.1.3 Increasing incidence and prevalence of chronic and
infectious diseases 49
TABLE 2 RISING GLOBAL INCIDENCE OF DISEASES 49
3.2.1.4 Growing focus on personalized medicine 49
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008–2020 50
3.2.1.5 Increasing government funding for cell-based research 50
3.2.2 RESTRAINTS 50
3.2.2.1 High cost of cell-based research 50
3.2.2.2 Lack of infrastructure for cell-based research in emerging economies 51
3.2.3 OPPORTUNITIES 51
3.2.3.1 Growth opportunities in emerging markets 51
3.2.3.2 Growth in stem cell research 52
3.2.3.3 Emergence of advanced tissue dissociation enzyme products 52
3.2.3.4 Acceptance of enzyme-free dissociation products over enzymatic dissociation products 52
3.2.4 CHALLENGES 52
3.2.4.1 Survival of small players and new entrants 52
3.2.4.2 Ethical concerns regarding research in cell biology 53
3.3 COVID-19 IMPACT ANALYSIS 53
4 EXECUTIVE SUMMARY 54
FIGURE 12 CELL DISSOCIATION MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 54
FIGURE 13 CELL DISSOCIATION MARKET, BY TISSUE, 2021 VS. 2026 (USD MILLION) 55
FIGURE 14 CELL DISSOCIATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 55
FIGURE 15 CELL DISSOCIATION MARKET, BY END USER, 2021 VS. 2021 (USD MILLION) 56
FIGURE 16 CELL DISSOCIATION MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 56
5 PREMIUM INSIGHTS 58
5.1 CELL DISSOCIATION MARKET OVERVIEW 58
FIGURE 17 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 58

5.2 CELL DISSOCIATION MARKET, BY PRODUCT 58
FIGURE 18 ENZYMATIC DISSOCIATION PRODUCTS SEGMENT ACCOUNTED FOR
THE LARGEST MARKET SHARE IN 2020 58
5.3 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TYPE AND COUNTRY, 2020 59
FIGURE 19 US DOMINATED THE NORTH AMERICAN CELL DISSOCIATION
MARKET IN 2020 59
5.4 GEOGRAPHICAL SNAPSHOT OF THE CELL DISSOCIATION MARKET 59
FIGURE 20 INDIA TO REGISTER THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 59
6 CELL DISSOCIATION MARKET, BY PRODUCT 60
6.1 INTRODUCTION 61
TABLE 4 CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 61
TABLE 5 CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 61
6.2 ENZYMATIC DISSOCIATION PRODUCTS 62
6.2.1 COLLAGENASE ACCOUNTED FOR THE LARGEST SHARE OF
THE ENZYMATIC DISSOCIATION PRODUCTS MARKET IN 2020 62
TABLE 6 ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 62
TABLE 7 ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 62
6.2.2 COLLAGENASE 63
TABLE 8 COLLAGENASE MARKET, BY REGION, 2016–2019 (USD MILLION) 63
TABLE 9 COLLAGENASE MARKET, BY REGION, 2020–2026 (USD MILLION) 63
6.2.3 TRYPSIN 64
TABLE 10 TRYPSIN MARKET, BY REGION, 2016–2019 (USD MILLION) 64
TABLE 11 TRYPSIN MARKET, BY REGION, 2020–2026 (USD MILLION) 64
6.2.4 PAPAIN 65
TABLE 12 PAPAIN MARKET, BY REGION, 2016–2019 (USD MILLION) 65
TABLE 13 PAPAIN MARKET, BY REGION, 2020–2026 (USD MILLION) 65
6.2.5 ELASTASE 65
TABLE 14 ELASTASE MARKET, BY REGION, 2016–2019 (USD MILLION) 66
TABLE 15 ELASTASE MARKET, BY REGION, 2020–2026 (USD MILLION) 66
6.2.6 DNASE 66
TABLE 16 DNASE MARKET, BY REGION, 2016–2019 (USD MILLION) 66
TABLE 17 DNASE MARKET, BY REGION, 2020–2026 (USD MILLION) 67
6.2.7 HYALURONIDASE 67
TABLE 18 HYALURONIDASE MARKET, BY REGION, 2016–2029 (USD MILLION) 67
TABLE 19 HYALURONIDASE MARKET, BY REGION, 2020–2026 (USD MILLION) 68
6.2.8 OTHER ENZYMES 68
TABLE 20 OTHER ENZYMES MARKET, BY REGION, 2016–2019 (USD MILLION) 68
TABLE 21 OTHER ENZYMES MARKET, BY REGION, 2020–2026 (USD MILLION) 68

6.3 NON-ENZYMATIC DISSOCIATION PRODUCTS 69
6.3.1 NON-ENZYMATIC DISSOCIATION PRODUCTS MAXIMIZE THE YIELD OF
VIABLE CELLS DURING THE DISSOCIATION PROCESS 69
TABLE 22 NON-ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY REGION,
2016–2019 (USD MILLION) 69
TABLE 23 NON-ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY REGION,
2020–2026 (USD MILLION) 70
6.4 INSTRUMENTS & ACCESSORIES 70
6.4.1 THE INCREASING PREVALENCE OF CELL-BASED RESEARCH DRIVES
THE MARKET GROWTH FOR TISSUE DISSOCIATORS AND ACCESSORIES 70
TABLE 24 CELL DISSOCIATION INSTRUMENTS & ACCESSORIES MARKET, BY REGION, 2016–2019 (USD MILLION) 70
TABLE 25 CELL DISSOCIATION INSTRUMENTS & ACCESSORIES MARKET, BY REGION, 2020–2026 (USD MILLION) 71
7 CELL DISSOCIATION MARKET, BY TISSUE 72
7.1 INTRODUCTION 73
TABLE 26 CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION) 73
TABLE 27 CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION) 73
7.2 CONNECTIVE TISSUE 73
7.2.1 THE CONNECTIVE TISSUE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE CELL DISSOCIATION MARKET IN 2020 73
TABLE 28 CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY REGION,
2016–2019 (USD MILLION) 74
TABLE 29 CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY REGION,
2020–2026 (USD MILLION) 74
7.3 EPITHELIAL TISSUE 75
7.3.1 THE EPITHELIAL TISSUE SEGMENT ACCOUNTED FOR THE SECOND-LARGEST SHARE OF THE CELL DISSOCIATION MARKET IN 2020 75
TABLE 30 CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY REGION,
2016–2019 (USD MILLION) 75
TABLE 31 CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY REGION,
2020–2026 (USD MILLION) 76
7.4 OTHER TISSUES 76
TABLE 32 CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY REGION,
2016–2019 (USD MILLION) 77
TABLE 33 CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY REGION,
2020–2026 (USD MILLION) 77
8 CELL DISSOCIATION MARKET, BY TYPE 78
8.1 INTRODUCTION 79
TABLE 34 CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 79
TABLE 35 CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 79
8.2 TISSUE DISSOCIATION 79
8.2.1 INCREASING R&D EXPENDITURE IN THE PHARMACEUTICAL INDUSTRY DRIVES SEGMENT GROWTH 79
TABLE 36 CELL DISSOCIATION MARKET FOR TISSUE DISSOCIATION, BY REGION,
2016–2019 (USD MILLION) 80
TABLE 37 CELL DISSOCIATION MARKET FOR TISSUE DISSOCIATION, BY REGION,
2020–2026 (USD MILLION) 80
8.3 CELL DETACHMENT 81
8.3.1 CELL DETACHMENT IS PERFORMED IN STEM CELL & CELL CULTURE STUDIES 81
TABLE 38 CELL DISSOCIATION MARKET FOR CELL DETACHMENT, BY REGION,
2016–2019 (USD MILLION) 81
TABLE 39 CELL DISSOCIATION MARKET FOR CELL DETACHMENT, BY REGION,
2020–2026 (USD MILLION) 82
9 CELL DISSOCIATION MARKET, BY END USER 83
9.1 INTRODUCTION 84
TABLE 40 CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION) 84
TABLE 41 CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION) 84
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 85
9.2.1 INCREASING INVESTMENTS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 85
TABLE 42 CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2019 (USD MILLION) 86
TABLE 43 CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2026 (USD MILLION) 86
9.3 RESEARCH & ACADEMIC INSTITUTES 86
9.3.1 GROWING FUNDING FOR CELL-BASED RESEARCH DRIVES
THE MARKET GROWTH 86
TABLE 44 CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES,
BY REGION, 2016-2019 (USD MILLION) 87
TABLE 45 CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES,
BY REGION, 2020–2026 (USD MILLION) 87
9.4 OTHER END USERS 88
TABLE 46 RECENT MERGERS & ACQUISITIONS AMONG CONTRACT
RESEARCH ORGANIZATIONS 88
TABLE 47 CELL DISSOCIATION MARKET FOR OTHER END USERS, BY REGION,
2016-2019 (USD MILLION) 89
TABLE 48 CELL DISSOCIATION MARKET FOR OTHER END USERS, BY REGION,
2020–2026 (USD MILLION) 89
10 CELL DISSOCIATION MARKET, BY REGION 90
10.1 INTRODUCTION 91
TABLE 49 CELL DISSOCIATION MARKET, BY REGION, 2016–2019 (USD MILLION) 91
TABLE 50 CELL DISSOCIATION MARKET, BY REGION, 2020–2026 (USD MILLION) 91
10.2 NORTH AMERICA 92
FIGURE 21 NORTH AMERICA: CELL DISSOCIATION MARKET SNAPSHOT 93
TABLE 51 NORTH AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 93
TABLE 52 NORTH AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 94
TABLE 53 NORTH AMERICA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 94
TABLE 54 NORTH AMERICA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 94
TABLE 55 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TISSUE,
2016–2019 (USD MILLION) 95
TABLE 56 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TISSUE,
2020–2026 (USD MILLION) 95
TABLE 57 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TYPE,
2016–2019 (USD MILLION) 95
TABLE 58 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TYPE,
2020–2026 (USD MILLION) 95
TABLE 59 NORTH AMERICA: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 96
TABLE 60 NORTH AMERICA: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 96
10.2.1 US 96
10.2.1.1 The presence of an established pharmaceutical & biotechnology sector drives market growth for cell dissociation products 96
TABLE 61 US: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 97
TABLE 62 US: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 97
TABLE 63 US: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 98
TABLE 64 US: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 98
TABLE 65 US: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION) 98
TABLE 66 US: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION) 99
TABLE 67 US: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 99
TABLE 68 US: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 99
TABLE 69 US: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION) 99
TABLE 70 US: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION) 100
10.2.2 CANADA 100
10.2.2.1 Advancements in the field of regenerative medicine to drive market growth in Canada 100
TABLE 71 CANADA: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 101
TABLE 72 CANADA: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 101
TABLE 73 CANADA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 101
TABLE 74 CANADA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 102
TABLE 75 CANADA: CELL DISSOCIATION MARKET, BY TISSUE,
2016–2019 (USD MILLION) 102
TABLE 76 CANADA: CELL DISSOCIATION MARKET, BY TISSUE,
2020–2026 (USD MILLION) 102
TABLE 77 CANADA: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 103
TABLE 78 CANADA: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 103
TABLE 79 CANADA: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 103
TABLE 80 CANADA: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 103
10.3 EUROPE 104
TABLE 81 EUROPE: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 104
TABLE 82 EUROPE: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 104
TABLE 83 EUROPE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 105
TABLE 84 EUROPE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 105
TABLE 85 EUROPE: CELL DISSOCIATION MARKET, BY TISSUE,
2016–2019 (USD MILLION) 105
TABLE 86 EUROPE: CELL DISSOCIATION MARKET, BY TISSUE,
2020–2026 (USD MILLION) 106
TABLE 87 EUROPE: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 106
TABLE 88 EUROPE: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 106
TABLE 89 EUROPE: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 106
TABLE 90 EUROPE: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 107
10.3.1 GERMANY 107
10.3.1.1 Germany dominated the market in Europe in 2020 107
TABLE 91 GERMANY: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 108
TABLE 92 GERMANY: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 108
TABLE 93 GERMANY: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 108
TABLE 94 GERMANY: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 109
TABLE 95 GERMANY: CELL DISSOCIATION MARKET, BY TISSUE,
2016–2019 (USD MILLION) 109
TABLE 96 GERMANY: CELL DISSOCIATION MARKET, BY TISSUE,
2020–2026 (USD MILLION) 109
TABLE 97 GERMANY: CELL DISSOCIATION MARKET, BY TYPE,
2016–2019 (USD MILLION) 110
TABLE 98 GERMANY: CELL DISSOCIATION MARKET, BY TYPE,
2020–2026 (USD MILLION) 110
TABLE 99 GERMANY: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 110
TABLE 100 GERMANY: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 110

10.3.2 UK 111
10.3.2.1 Government investments in the biotech industry to support
market growth in the UK 111
TABLE 101 UK: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 111
TABLE 102 UK: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 111
TABLE 103 UK: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 112
TABLE 104 UK: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 112
TABLE 105 UK: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION) 112
TABLE 106 UK: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION) 113
TABLE 107 UK: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 113
TABLE 108 UK: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 113
TABLE 109 UK: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION) 113
TABLE 110 UK: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION) 114
10.3.3 FRANCE 114
10.3.3.1 Increasing R&D investments by key players to support market
growth in France 114
TABLE 111 FRANCE: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 114
TABLE 112 FRANCE: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 115
TABLE 113 FRANCE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 115
TABLE 114 FRANCE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 115
TABLE 115 FRANCE: CELL DISSOCIATION MARKET, BY TISSUE,
2016–2019 (USD MILLION) 116
TABLE 116 FRANCE: CELL DISSOCIATION MARKET, BY TISSUE,
2020–2026 (USD MILLION) 116
TABLE 117 FRANCE: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 116
TABLE 118 FRANCE: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 116
TABLE 119 FRANCE: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 117
TABLE 120 FRANCE: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 117
10.3.4 ITALY 117
10.3.4.1 Large life sciences research base in Italy supports market growth for cell dissociation products 117
TABLE 121 ITALY: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 118
TABLE 122 ITALY: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 118
TABLE 123 ITALY: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 118
TABLE 124 ITALY: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 119
TABLE 125 ITALY: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION) 119
TABLE 126 ITALY: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION) 119
TABLE 127 ITALY: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 120
TABLE 128 ITALY: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 120
TABLE 129 ITALY: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 120
TABLE 130 ITALY: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 120
10.3.5 SPAIN 121
10.3.5.1 Increasing private & public funding to boost the
market growth in Spain 121
TABLE 131 SPAIN: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 121
TABLE 132 SPAIN: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 121
TABLE 133 SPAIN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 122
TABLE 134 . SPAIN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 122
TABLE 135 SPAIN: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION) 122
TABLE 136 SPAIN: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION) 123
TABLE 137 SPAIN: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 123
TABLE 138 SPAIN: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 123
TABLE 139 SPAIN: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 123
TABLE 140 SPAIN: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 124
10.3.6 REST OF EUROPE 124
TABLE 141 ROE: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 124
TABLE 142 ROE: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 125
TABLE 143 ROE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 125
TABLE 144 ROE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 125
TABLE 145 ROE: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION) 126
TABLE 146 ROE: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION) 126
TABLE 147 ROE: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 126
TABLE 148 ROE: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 126
TABLE 149 ROE: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 127
TABLE 150 ROE: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 127

10.4 ASIA PACIFIC 127
FIGURE 22 ASIA PACIFIC: CELL DISSOCIATION MARKET SNAPSHOT 128
TABLE 151 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 129
TABLE 152 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 129
TABLE 153 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 129
TABLE 154 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 130
TABLE 155 ASIA PACIFIC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 130
TABLE 156 ASIA PACIFIC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 130
TABLE 157 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TISSUE,
2016–2019 (USD MILLION) 131
TABLE 158 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TISSUE,
2020–2026 (USD MILLION) 131
TABLE 159 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TYPE,
2016–2019 (USD MILLION) 131
TABLE 160 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TYPE,
2020–2026 (USD MILLION) 131
TABLE 161 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 132
TABLE 162 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 132
10.4.1 JAPAN 132
10.4.1.1 Strategic developments by companies to drive the market growth for products in Japan 132
TABLE 163 JAPAN: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 133
TABLE 164 JAPAN: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 133
TABLE 165 JAPAN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 134
TABLE 166 JAPAN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 134
TABLE 167 JAPAN: CELL DISSOCIATION MARKET, BY TISSUE,
2016–2019 (USD MILLION) 134
TABLE 168 JAPAN: CELL DISSOCIATION MARKET, BY TISSUE,
2020–2026 (USD MILLION) 135
TABLE 169 JAPAN: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 135
TABLE 170 JAPAN: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 135
TABLE 171 JAPAN: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 135
TABLE 172 JAPAN: CELL DISSOCIATION MARKET, BY END USER,
2019–2026 (USD MILLION) 136

10.4.2 CHINA 136
10.4.2.1 China to register the highest growth rate in the Asia Pacific market during the forecast period 136
TABLE 173 CHINA: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 136
TABLE 174 CHINA: CELL DISSOCIATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 137
TABLE 175 CHINA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 137
TABLE 176 CHINA: DISSOCIATION PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 177 CHINA: CELL DISSOCIATION MARKET, BY TISSUE,
2016–2019 (USD MILLION) 138
TABLE 178 CHINA: CELL DISSOCIATION MARKET, BY TISSUE,
2020–2026 (USD MILLION) 138
TABLE 179 CHINA: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 138
TABLE 180 CHINA: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 138
TABLE 181 CHINA: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 139
TABLE 182 CHINA: CELL DISSOCIATION MARKET, BY END USER,
2019–2026 (USD MILLION) 139
10.4.3 INDIA 139
10.4.3.1 Growth initiatives to promote the life sciences industry to drive market growth in India 139
TABLE 183 INDIA: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 140
TABLE 184 INDIA: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 140
TABLE 185 INDIA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 140
TABLE 186 INDIA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 141
TABLE 187 INDIA: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION) 141
TABLE 188 INDIA: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION) 141
TABLE 189 INDIA: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 142
TABLE 190 INDIA: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 142
TABLE 191 INDIA: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 142
TABLE 192 INDIA: CELL DISSOCIATION MARKET, BY END USER,
2020–2026 (USD MILLION) 142
10.4.4 REST OF ASIA PACIFIC 143
TABLE 193 ROAPAC: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 143
TABLE 194 ROAPAC: CELL DISSOCIATION MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 144
TABLE 195 ROAPAC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 144
TABLE 196 ROAPAC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 197 ROAPAC: CELL DISSOCIATION MARKET, BY TISSUE,
2016–2019 (USD MILLION) 145
TABLE 198 ROAPAC: CELL DISSOCIATION MARKET, BY TISSUE,
2020–2026 (USD MILLION) 145
TABLE 199 ROAPAC: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 145
TABLE 200 ROAPAC: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 145
TABLE 201 ROAPAC: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 146
TABLE 202 ROAPAC: CELL DISSOCIATION MARKET, BY END USER,
2019–2026 (USD MILLION) 146
10.5 REST OF THE WORLD 146
TABLE 203 ROW: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 147
TABLE 204 ROW: CELL DISSOCIATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 147
TABLE 205 ROW: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 147
TABLE 206 ROW: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 207 ROW: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION) 148
TABLE 208 ROW: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION) 148
TABLE 209 ROW: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION) 149
TABLE 210 ROW: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION) 149
TABLE 211 ROW: CELL DISSOCIATION MARKET, BY END USER,
2016–2019 (USD MILLION) 149
TABLE 212 ROW: CELL DISSOCIATION MARKET, BY END USER,
2019–2026 (USD MILLION) 149
11 COMPETITIVE LANDSCAPE 150
11.1 OVERVIEW 150
FIGURE 23 KEY DEVELOPMENTS IN THE CELL DISSOCIATION MARKET,
JANUARY 2018–APRIL 2021 150
FIGURE 24 MARKET EVOLUTION MATRIX: JANUARY 2018 TO APRIL 2021 151
11.2 MARKET SHARE ANALYSIS 152
TABLE 213 CELL DISSOCIATION MARKET: DEGREE OF COMPETITION 152
11.3 COMPANY EVALUATION MATRIX 153
11.3.1 STARS 153
11.3.2 EMERGING LEADERS 153
11.3.3 PERVASIVE PLAYERS 153
11.3.4 PARTICIPANTS 153
FIGURE 25 VENDOR DIVE: CELL DISSOCIATION MARKET 154
11.4 COMPETITIVE LEADERSHIP MAPPING (SMES/ START-UPS) 155
11.4.1 PROGRESSIVE COMPANIES 155
11.4.2 STARTING BLOCKS 155
11.4.3 RESPONSIVE COMPANIES 155
11.4.4 DYNAMIC COMPANIES 155
FIGURE 26 VENDOR DIVE MATRIX FOR SMES & START-UPS:
CELL DISSOCIATION MARKET 156
11.5 COMPETITIVE SCENARIO 157
TABLE 214 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2018–APRIL 2021 157
11.5.1 DEALS 157
TABLE 215 KEY DEALS, JANUARY 2018–APRIL 2021 157
11.5.2 OTHER DEVELOPMENTS 158
TABLE 216 OTHER KEY DEVELOPMENTS, JANUARY 2018–APRIL 2021 158
11.6 COMPANY FOOTPRINT 158
TABLE 217 COMPANY FOOTPRINT 159
TABLE 218 COMPANY PRODUCT FOOTPRINT 160
TABLE 219 COMPANY CELL DISSOCIATION TYPE FOOTPRINT 161
TABLE 220 COMPANY GEOGRAPHICAL FOOTPRINT 162
12 COMPANY PROFILES 163
12.1 KEY PLAYERS 163
(Business Overview, Products Offered, and Recent Developments)*
12.1.1 THERMO FISHER SCIENTIFIC 163
TABLE 221 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 163
FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 164
12.1.2 MERCK KGAA 166
TABLE 222 MERCK KGAA: BUSINESS OVERVIEW 166
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2020) 167
12.1.3 BECTON, DICKINSON AND COMPANY 169
TABLE 223 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 169
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 170
12.1.4 STEMCELL TECHNOLOGIES 171
TABLE 224 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW 171
12.1.5 PROMOCELL GMBH 173
TABLE 225 PROMOCELL GMBH: BUSINESS OVERVIEW 173
12.1.6 F. HOFFMANN-LA ROCHE LTD. 175
TABLE 226 F. HOFFMAN-LA ROCHE LTD.: BUSINESS OVERVIEW 175
FIGURE 30 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020) 176
12.1.7 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION) 178
TABLE 227 CYTIVA: BUSINESS OVERVIEW 178
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 179
12.1.8 MILTENYI BIOTEC 181
TABLE 228 MILTENYI BIOTEC: BUSINESS OVERVIEW 181
12.1.9 ATCC 182
TABLE 229 ATCC: BUSINESS OVERVIEW 182
12.1.10 CORNING INC. 184
TABLE 230 CORNING INC.: BUSINESS OVERVIEW 184
FIGURE 32 CORNING INC.: COMPANY SNAPSHOT (2020) 185
12.1.11 HIMEDIA LABORATORIES 186
TABLE 231 HIMEDIA LABORATORIES: BUSINESS OVERVIEW 186
12.1.12 PAN-BIOTECH 188
TABLE 232 PAN-BIOTECH: BUSINESS OVERVIEW 188
12.1.13 ACCEGEN 190
TABLE 233 ACCEGEN: BUSINESS OVERVIEW 190
12.1.14 CELLSYSTEMS GMBH 191
TABLE 234 CELLSYSTEMS: BUSINESS OVERVIEW 191
12.1.15 AMSBIO 194
TABLE 235 AMSBIO: BUSINESS OVERVIEW 194
12.2 OTHER PLAYERS 196
12.2.1 VITACYTE 196
TABLE 236 VITACYTE: BUSINESS OVERVIEW 196
12.2.2 ALSTEMBIO CELL ADVANCEMENT 198
TABLE 237 ALSTEM: BUSINESS OVERVIEW 198
12.2.3 BIOLOGICAL INDUSTRIES 199
TABLE 238 BIOLOGICAL INDUSTRIES: BUSINESS OVERVIEW 199
12.2.4 GEMINI BIO-PRODUCTS 201
TABLE 239 GEMINI BIO-PRODUCTS: BUSINESS OVERVIEW 201
12.2.5 INNOVATIVE CELL TECHNOLOGIES, INC. 203
TABLE 240 INNOVATIVE CELL TECHNOLOGIES, INC.: BUSINESS OVERVIEW 203
12.2.6 CENTRAL DRUG HOUSE (P) LTD. 204
TABLE 241 CENTRAL DRUG HOUSE (P) LTD.: BUSINESS OVERVIEW 204
12.2.7 R&D SYSTEMS (BIO-TECHNE) 205
TABLE 242 R&D SYSTEMS: BUSINESS OVERVIEW 205
12.2.8 WORTHINGTON BIOCHEMICAL CORPORATION 206
TABLE 243 WORTHINGTON BIOCHEMICAL CORPORATION: BUSINESS OVERVIEW 206
12.2.9 CAPRICORN SCIENTIFIC 208
TABLE 244 CAPRICORN SCIENTIFIC: BUSINESS OVERVIEW 208
12.2.10 ABEOMICS 209
TABLE 245 ABEOMICS: BUSINESS OVERVIEW 209
12.2.11 GENLANTIS 210
TABLE 246 GENLANTIS: BUSINESS OVERVIEW 210
12.2.12 NEUROMICS 211
TABLE 247 NEUROMICS: BUSINESS OVERVIEW 211
* Business Overview, Products Offered, and Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX 212
13.1 INSIGHTS FROM INDUSTRY EXPERTS 212
13.2 DISCUSSION GUIDE 213
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 217
13.4 AVAILABLE CUSTOMIZATIONS 219
13.5 RELATED REPORTS 219
13.6 AUTHOR DETAILS 220



★調査レポート[世界の細胞解離市場予測:製品別、種類別、組織別、エンドユーザー別] ( Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) - Global Forecast to 2026 / BT6129) 販売に関する免責事項
[世界の細胞解離市場予測:製品別、種類別、組織別、エンドユーザー別] ( Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) - Global Forecast to 2026 / BT6129) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆